Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04474301

Conditions

COVID-19 Infection

Melanoma

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Survey Administration

Study Details

Brief summary:

The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.

Conditions

COVID-19 Infection

Melanoma

Study ID

NCT04474301

Start date

Jun 11, 2020

Status verified date

Apr, 2026

Completion date

Dec 30, 2026

Anticipated

Primary completion date

Dec 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who have signed consent for PA15-0336
  • Has an active email address and can be contacted via MyChart
  • Documentation of being alive per the cancer registry

Study Design

Enrollment

1152 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (survey administration)

Patients complete a survey over 10 minutes.

Interventions

Survey Administration

Complete survey

Primary outcome measure

  • Experiences during the COVID-19 pandemic [ Time Frame: Survey completion Up to 2 months ]
  • COVID-19-specific psychological distress [ Time Frame: Survey completion Up to 2 months ]
  • COVID-19-specific health [ Time Frame: Survey completion Up to 2 months ]
  • COVID-19-specific financial and social disruptions [ Time Frame: Survey completion Up to 2 months ]
  • COVID-19-specific perceived benefits and social support [ Time Frame: Survey completion Up to 2 months ]
  • COVID-19-specific health related quality of life (HRQoL) [ Time Frame: Survey completion Up to 2 months ]
  • Effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL [ Time Frame: Survey completion Up to 2 months ]
  • Prior lifestyle data [ Time Frame: Survey completion Up to 2 months ]

Central Contacts and Locations

Central contacts

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Principal Investigator:

Lorenzo Cohen

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Apr 16, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-04-16.